GLP-1s and Addiction Recovery: A Modern Integrative Model for Healing at Carrara Treatment Wellness & Spa

At Carrara Treatment Wellness & Spa, healing isn’t just clinical—it’s an art. This month, we’re proud to share stories that reflect the depth, precision, and possibility of our integrative approach.

Dr. Kenny Spielvogel
Senior Medical Officer

A Case in Recovery: Repairing the Body to Heal the Mind

John, a 45-year-old executive, arrived at Carrara exhausted and demoralized after years of alcohol use. His liver enzymes were elevated, his sleep erratic, and his motivation gone. Traditional detox had helped him get sober before—but never well.

At Carrara, we view recovery through a metabolic and neurobiological lens. The first step was stabilization, which involved repairing the liver, calming anxiety, and restoring sleep and the circadian rhythm.

He began taking silymarin (milk thistle) and N-acetylcysteine (NAC) to reduce oxidative liver stress and replenish glutathione; omega-3 fatty acids for neuronal repair and inflammation control; and magnesium glycinate with L-theanine for anxiety and sleep support. Within two weeks, his mood and focus began to lift.

Phase One: Stabilization and the Science of Craving

Chronic alcohol exposure rewires dopamine pathways, blunting natural reward and increasing compulsive drive. This is where GLP-1 receptor agonists—initially developed for the treatment of diabetes and obesity—offer a powerful new lever. GLP-1 receptors are active not only in the pancreas but also in the ventral tegmental area and nucleus accumbens, key centers in the brain’s reward circuit. When stimulated, GLP-1 signaling reduces dopamine spikes, lowering the rewarding impact of alcohol, nicotine, and other addictive substances. Recent data are compelling: a 2025 JAMA Psychiatry randomized trial found weekly semaglutide significantly reduced alcohol intake and cravings. Extensive population studies have reported up to 50 % lower relapse rates among GLP-1 users compared with other weight-loss medications. At Carrara, we initiated low-dose semaglutide as part of John’s metabolic recovery—both for weight normalization and to re-tune his dopamine and insulin signaling.

Phase Two: Repair, Regeneration, and Resilience

After three months, John’s energy, sleep, and labs had normalized. This was the window to introduce targeted amino acids and research peptides to enhance neuroplasticity, tissue repair, and stress tolerance.

Investigational Peptides (Research-Use Only)

BPC-157 – A synthetic fragment of a gastric peptide with preclinical data showing accelerated healing and reduced inflammation in muscle, liver, and gut.
CJC-1295 + Ipamorelin – Stimulates natural growth-hormone release, supporting lean mass, bone density, and recovery; early human data but not FDA-approved.
Selank / Semax – Russian neuropeptides shown in small studies to improve focus and reduce anxiety through GABA and BDNF modulation.

While only GLP-1 analogs are FDA-approved, these research peptides offer promising biologic tools when used under medical supervision. Carrara integrates them thoughtfully—never as shortcuts, but as adjuncts to behavioral, nutritional, and physiologic therapy.

Phase Three: Lifestyle as Medicine

Once stable, John transitioned into physiologic restoration—harnessing environmental stress to strengthen resilience.

Infrared and Finnish Sauna: 3–4 sessions per week stimulate heat-shock proteins, reduce systemic inflammation, and improve endothelial function. Long-term studies link regular sauna use with lower cardiovascular mortality and enhanced mood.
Cold Plunge: Short bouts of immersion trigger catecholamine release, boost dopamine, and enhance vagal tone—supporting calm alertness.
Breathwork & Meditation: Controlled 5–6 breaths per minute breathing synchronizes heart-rate variability, improving stress recovery and emotional regulation.
Guided Exercise: Progressive resistance and low-intensity cardio rebuild mitochondrial capacity, improve insulin sensitivity, and restore physical confidence.

Sobriety became, for John, a foundation for performance—not merely abstinence.

The Science Behind the Supplements

Intervention

Mechanism of Action

Supporting Evidence

N-Acetyl Cysteine	Restores glutathione; modulates glutamate in reward circuits	RCTs show modest craving reduction; safe long-term
Omega-3 Fatty Acids	Anti-inflammatory; stabilizes neuronal membranes	Evidence for improved mood, cognition, and hepatic fat reduction
Magnesium + L-Theanine	GABAergic modulation; improves sleep quality	Small trials support anxiety reduction
GLP-1 Agonists (Semaglutide, Liraglutide)	Modulate dopamine and insulin pathways	Human trials show reduced alcohol intake and craving
Peptides (BPC-157, CJC-1295/Ipamorelin, Selank/Semax)	Tissue repair, GH modulation, neuroprotection	Early-stage or preclinical data; research use only

Ethical and Regulatory Perspective

At Carrara, patient safety and transparency are central.

GLP-1 agonists are FDA-approved for diabetes and obesity, but off-label for addiction.
Other peptides are not FDA-approved and are used only under research or wellness frameworks with informed consent, verified sourcing, and ongoing monitoring.
All supplement protocols are lab-guided, emphasizing data over trends.

Reimagining Recovery

Addiction is not merely a failure of willpower; it is a metabolic and neurochemical disruption. Healing requires more than abstinence—it demands cellular renewal, nervous-system recalibration, and metabolic balance.

Carrara Treatment Wellness & Spa’s model blends medicine and restoration: GLP-1 therapy to rebalance the brain, nutraceuticals and peptides to heal the body, and mind-body practices to strengthen the spirit. Recovery becomes not an ending, but a beginning—a journey from depletion to vitality.

The Carrara Recovery Framework

Stage 1 – Stabilization (Weeks 0–4)

Medical detox, anxiety and sleep regulation
Liver and antioxidant support: silymarin, NAC, omega-3
Gentle movement and breathwork initiation

Stage 2 – Metabolic Repair (Weeks 2-12)

Add GLP-1 RA (semaglutide/tirzepatide)
Consider research peptides (BPC-157, CJC-1295) under supervision
Add GLP-1 RA (semaglutide/tirzepatide)

Stage 3 – Regeneration (Months 3–6)

Consider research peptides (BPC-157, CJC-1295) under supervision
Add GLP-1 RA (semaglutide/tirzepatide)
Strength and body-composition optimization

Stage 4 – Longevity (Beyond 6 Months)

Hormonal, cardiovascular, and cognitive optimization
Personalized maintenance of peptides, nutrition, and somatic therapies
Strength and body-composition optimization

(Visual version suggestion: four horizontal panels showing “Stabilize → Repair → Regenerate → Thrive,” each with icons—liver 🫀 → brain 🧠 → muscle 💪 → lotus 🌿.)

Key References

JAMA Psychiatry, 2025 — Semaglutide reduces alcohol craving and consumption in adults with AUD.

Madsen A N et al., Nat Med, 2019 — GLP-1 receptor activation modulates mesolimbic dopamine and reward.

Thomsen K R et al., Transl Psychiatry, 2024 — GLP-1 analogs lower relapse risk in population cohorts.

Lucena A et al., Clin Pharmacol Ther, 2022 — Milk thistle meta-analysis in alcoholic liver disease.

LaRowe S D et al., Am J Psychiatry, 2020 — NAC reduces cocaine and alcohol cravings.

Grosso G et al., Nutrients, 2023 — Omega-3 supplementation and mood stabilization.

Wienecke E et al., Front Psychiatry, 2024 — Magnesium and theanine synergy for anxiety.

Jeong Y et al., Biomed Pharmacother, 2023 — Preclinical healing effects of BPC-157.

Richards R et al., Endocr Res, 2020 — CJC-1295 + GHRPs and body composition.

Panchenko L A et al., Neurosci Behav Physiol, 2019 — Selank/Semax neurocognitive effects.

Laukkanen J A et al., JAMA Intern Med, 2018 — Sauna bathing and reduced mortality.

Kox M et al., PNAS, 2014 — Cold exposure and breath-control increase norepinephrine and immune resilience.

Wienecke E et al., Front Psychiatry, 2024 — Magnesium and theanine synergy for anxiety.